Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma.

[1]  J. Neugarten,et al.  Female sex reduces the risk of hospital-associated acute kidney injury: a meta-analysis , 2018, BMC Nephrology.

[2]  W. Richards,et al.  A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  B. Afşar,et al.  Hyperthermic intraperitonal chemotherapy is an independent risk factor for development of acute kidney injury. , 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[4]  N. Kolhe,et al.  Sex differences in acute kidney injury requiring dialysis , 2018, BMC Nephrology.

[5]  N. Aaronson,et al.  Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer , 2018, The New England journal of medicine.

[6]  S. Mehta,et al.  Long-Term Renal Outcomes after Cisplatin Treatment. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[7]  A. Ginde,et al.  Minor Postoperative Increases of Creatinine Are Associated with Higher Mortality and Longer Hospital Length of Stay in Surgical Patients , 2015, Anesthesiology.

[8]  Tezcan Ozrazgat-Baslanti,et al.  Cost and Mortality Associated With Postoperative Acute Kidney Injury. , 2015, Annals of surgery.

[9]  D. Leaf,et al.  Intraoperative High-Dose Dexamethasone and Severe AKI after Cardiac Surgery. , 2015, Journal of the American Society of Nephrology : JASN.

[10]  M. Nematbakhsh,et al.  Gender Difference in Cisplatin-Induced Nephrotoxicity in a Rat Model: Greater Intensity of Damage in Male Than Female , 2013, Nephro-urology monthly.

[11]  M. Ried,et al.  Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignancies , 2013, Journal of surgical oncology.

[12]  A. Khwaja.  KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.

[13]  D. Sugarbaker,et al.  Use of postoperative creatinine to predict sustained kidney injury in patients undergoing mesothelioma surgery. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[14]  J. Bonventre,et al.  Cellular pathophysiology of ischemic acute kidney injury. , 2011, The Journal of clinical investigation.

[15]  B. McCaughan,et al.  Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors. , 2009, The Journal of thoracic and cardiovascular surgery.

[16]  D. Sugarbaker,et al.  Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. , 2009, Seminars in thoracic and cardiovascular surgery.

[17]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[18]  H. Krumholz,et al.  Long-term prognosis of acute kidney injury after acute myocardial infarction. , 2008, Archives of internal medicine.

[19]  I. Heilberg,et al.  Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[20]  Chan-Yu Lin,et al.  Evaluation of outcome scoring systems for patients on extracorporeal membrane oxygenation. , 2007, The Annals of thoracic surgery.

[21]  V. Rousson,et al.  Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[22]  P. Jänne,et al.  Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Y. Ahn,et al.  Testosterone Is Responsible for Enhanced Susceptibility of Males to Ischemic Renal Injury* , 2004, Journal of Biological Chemistry.

[24]  R. Stahel,et al.  Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  W. Richards,et al.  Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. , 2004, The Journal of thoracic and cardiovascular surgery.

[26]  T. Boulikas,et al.  Cisplatin and platinum drugs at the molecular level. (Review). , 2003, Oncology reports.

[27]  Claude Denham,et al.  Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  O. van Tellingen,et al.  Pharmacokinetics of doxorubicin and cisplatin used in intraoperative hyperthermic intrathoracic chemotherapy after cytoreductive surgery for malignant pleural mesothelioma and pleural thymoma , 2003, Anti-cancer drugs.

[29]  P. Sugarbaker.  Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. , 1998, Seminars in surgical oncology.

[30]  V. Rusch,et al.  Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Storm Fk.  Clinical hyperthermia and chemotherapy. , 1989 .

[32]  F. K. Storm,et al.  Clinical hyperthermia and chemotherapy. , 1989, Radiologic clinics of North America.

[33]  R. Safirstein,et al.  Uptake and metabolism of cisplatin by rat kidney. , 1984, Kidney international.

[34]  M. Weiner,et al.  Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. , 1980, The Journal of pharmacology and experimental therapeutics.

[35]  G. Hahn,et al.  Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Mussi,et al.  Pleural recurrence of thymoma: surgical resection followed by hyperthermic intrathoracic perfusion chemotherapy†. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[37]  W. Richards,et al.  Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. , 1999, The Journal of thoracic and cardiovascular surgery.